首页> 外文期刊>Journal of assisted reproduction and genetics >Effect of seminal plasma application to the vaginal vault in in vitro fertilization or intracytoplasmic sperm injection treatment cycles - A double-blind, placebo-controlled, randomized study
【24h】

Effect of seminal plasma application to the vaginal vault in in vitro fertilization or intracytoplasmic sperm injection treatment cycles - A double-blind, placebo-controlled, randomized study

机译:在体外受精或胞浆内精子注射治疗周期中,将精浆应用于阴道穹ault的影响-一项双盲,安慰剂对照的随机研究

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To study whether intravaginal application of seminal plasma after follicle aspiration has the potential to increase implantation and clinical pregnancy rates after IVF-ET. Methods: We conducted a prospective, double-blind, placebo-controlled randomized study of 230 patients undergoing IVF-ET cycles. 500 μL of Fresh seminal plasma from the patient's partner or culture medium (placebo) were injected in the vaginal vault just after follicle aspiration. The main outcome measured was ongoing clinical-pregnancy rate. Results: After ET cancellation in ten patients due to lack of fertilization or embryo cleavage, 220 embryo transfers (103 and 117 in the study and control groups) resulted in a clinical pregnancy rate of 36.9 % and 29.1 % for the study and control groups, corresponding to a relative increase of 26.8 %. After an early pregnancy loss of 13.1 % (5/38) and 23.5 % (8/34) in the study and control groups respectively an ongoing pregnancy rate of 32.0 % (33/103) and 22.2 % (26/117) was achieved corresponding to a relative increase of 44.1 %. Multivariate logistic regression analysis adjusted for study group, age, infertility, and cycle characteristics did not demonstrate any parameter that could predict occurrence of clinical pregnancy rates after IVF-ET. Conclusions: Patients who underwent SP intravaginal insemination after oocyte pick-up reached higher implantation and clinical pregnancy rates following ET compared to controls, although the difference did not reach statistical significance. More studies and variable methodologies may clarify the potential clinical effect of SP in improving live birth rates after ART.
机译:目的:研究卵泡抽吸后阴道内输精液的使用是否有可能增加IVF-ET后的着床率和临床妊娠率。方法:我们对230名接受IVF-ET周期治疗的患者进行了一项前瞻性,双盲,安慰剂对照的随机研究。卵泡抽吸后,将500μL来自患者伴侣或培养基(安慰剂)的新鲜精浆注射到阴道穹ault中。测得的主要结局是持续的临床妊娠率。结果:10名患者由于缺乏受精或胚胎分裂而取消ET后,进行了220次胚胎移植(研究组和对照组为103和117个),导致研究组和对照组的临床妊娠率为36.9%和29.1%,相对增加了26.8%。在研究组和对照组中分别减少了13.1%(5/38)和23.5%(8/34)的早期妊娠后,持续妊娠率达到了32.0%(33/103)和22.2%(26/117)相对增加了44.1%。对研究组,年龄,不育和周期特征进行调整的多元逻辑回归分析未显示任何可预测IVF-ET后临床妊娠率发生的参数。结论:与对照组相比,卵母细胞拾取后进行SP阴道授精的患者在ET后的植入率和临床妊娠率更高,尽管差异没有统计学意义。更多的研究和可变的方法可能会阐明SP改善ART后活产率的潜在临床效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号